Skip to main content
PMC home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2017 May 3;31(5):1252. doi: 10.1038/leu.2017.2

Erratum: A randomized study of pomalidomide vs placebo in persons with myeloproliferative neoplasm-associated myelofibrosis and RBC-transfusion dependence

A Tefferi, H K Al-Ali, G Barosi, T Devos, H Gisslinger, Q Jiang, J-J Kiladjian, R Mesa, F Passamonti, M F McMullin, V Ribrag, G Schiller, A M Vannucchi, D Zhou, D Reiser, J Zhong, R P Gale; for the RESUME trialists
PMCID: PMC7608297  PMID: 28465517

Correction to: Leukemia advance online publication 18 November 2016; doi:10.1038/leu.2016.300

Following the online publication of this article, the authors noted that Dr McMullin was incorrectly excluded from the author list. The complete author names are given above. Dr McMullin’s affiliation is Department of Haematology, Queen’s University, Belfast, UK.

Footnotes

The online version of the original article can be found at 10.1038/leu.2016.300

Articles from Leukemia are provided here courtesy of Nature Publishing Group

RESOURCES